rate contract for medicines pk_ii - albendazole 400 mg tab, febuxostat 40 mg tab, atracurium besylate 10mg/ml inj, atropine sulphate 0.6 mg/ml inj, bisacodyl 5 mg enteric coated ip tab, cetrizine 5mg/5ml syrup, chlordiazepoxide 10mg tab, chlorhexidine gluconate 0.2% sol., dicyclomine 10mg + mefenamic cid 250 mg, dicyclomine hcl 10mg/ml inj, hyocine butyl bromide 20mg/ml inj, lorazepam 1mg tab, lorazepam 2 mg tab, ondensetron usp 2 mg/ml inj, ornidazole 500 mg tab, pheniramine maleate 22.75 mg/ml

Punjab Health Systems Corporation has invited bids for the rate contract for medicines pk_ii - albendazole 400 mg tab, febuxostat 40 mg tab, atracurium besylate 10mg/ml inj, atropine sulphate 0.6 mg/ml inj, bisacodyl 5 mg enteric coated ip tab, cetrizine 5mg/5ml syrup, chlordiazepoxide 10mg tab, chlorhexidine gluconate 0.2% sol., dicyclomine 10mg + mefenamic cid 250 mg, dicyclomine hcl 10mg/ml inj, hyocine butyl bromide 20mg/ml inj, lorazepam 1mg tab, lorazepam 2 mg tab, ondensetron usp 2 mg/ml inj, ornidazole 500 mg tab, pheniramine maleate 22.75 mg/ml inj, phenobarbitone 60 mg tab, propofol 10 mg/ml inj, tranexamic acid 500mg (tranexamic acid, ip coated) tab, trihexiphenidyl 2 mg tab, natural micronised progesterone 200 mg cap., oxytocin 5 iu/ml inj.. Please refer to the tender document for project value and EMD details. Interested bidders can submit applications until 1 October 2026, with the technical opening scheduled for 5 October 2026.